Getinge flagged a SEK400m on Q2 23 EBITA due to additional quality and supply challenges in Acute Care Therapies. These issues are likely to affect sales, mix, and earnings for the remainder of the year. The headwinds should decrease to around SEK200m in Q3, with the belief that lost revenue is temporary. Our FY23 estimates will be reduced by double-digits, but the impact on FY24 is expected to be less severe.
20 Jun 2023
A double-whammy leads to a profit warning
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
A double-whammy leads to a profit warning
- Published:
20 Jun 2023 -
Author:
Virendra Chauhan -
Pages:
3
Getinge flagged a SEK400m on Q2 23 EBITA due to additional quality and supply challenges in Acute Care Therapies. These issues are likely to affect sales, mix, and earnings for the remainder of the year. The headwinds should decrease to around SEK200m in Q3, with the belief that lost revenue is temporary. Our FY23 estimates will be reduced by double-digits, but the impact on FY24 is expected to be less severe.